Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06138236

Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides

Comparison of ESWT and Collagen Hydrolyzed Peptides in the Treatment of Plantar Fascitiis

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.

Detailed description

Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments. Aim of the study was to consider any difference in the outcome of the three groups of patients. The NRS and the AFAS score were considered for the outcome measurement.

Conditions

Interventions

TypeNameDescription
DRUGCollagen hydrolyzed peptidesinfiltration near the heal spur of 2ml of Arthrys

Timeline

Start date
2023-07-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-11-18
Last updated
2025-12-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06138236. Inclusion in this directory is not an endorsement.